US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

54.10

-1.1700-2.12%

Post-market: 54.420.3200+0.59%19:55 EDT

Volume:1.46M

Turnover:79.31M

Market Cap:10.39B

PE:30.06

High:55.62

Open:55.37

Low:53.79

Close:55.27

52wk High:66.28

52wk Low:50.76

Shares:192.11M

Float Shares:178.10M

Volume Ratio:1.08

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.80

EPS(LYR):1.80

ROE:5.94%

ROA:5.58%

PB:1.71

PE(LYR):30.06

Loading ...

Overview Company News Filings

Is It Time To Reassess BioMarin Pharmaceutical (BMRN) After A 42.7% Three-Year Share Price Fall

Simply Wall St.

RBC Capital Sticks to Their Hold Rating for BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Secures European Regulatory Approval for Amicus Therapeutics Acquisition

MT Newswires Live

What BioMarin Pharmaceutical (BMRN)'s Voxzogo Trial Stops and Mixed Safety Data Mean For Shareholders

Simply Wall St.

Exploring High Growth Tech Stocks In The US Market March 2026

Simply Wall St.

Wells Fargo says buy BioMarin shares amid Phase 2 trial discontinuation weakness

BioMarin halts Phase 2 VOXZOGO dosing and enrollment in Turner syndrome, SHOX-deficiency and ACAN-deficiency trials

Biomarin: Decision to Discontinue Following Occurrence of Several Slipped Capital Femoral Epiphysis Events in 2 Ongoing Investigator-Sponsored Trials

THOMSON REUTERS

Biomarin Pharmaceutical - Phase 2 Canopy Trials of Voxzogo in Noonan Syndrome, Idiopathic Short Stature to Continue - SEC Filing

THOMSON REUTERS

BioMarin reports VOXZOGO trial data showing 4.7 cm additional height gain at four years in children with achondroplasia treated before age 2

BioMarin Pharmaceutical Is Maintained at Buy by B of A Securities

Biomarin Pharmaceutical Inc : Bofa Global Research Cuts Price Objective to $85.00 From $97.00

THOMSON REUTERS

BioMarin price target lowered to $85 from $97 at BofA

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

PALYNZIQ Pediatric Label Expansion Under REMS Might Change The Case For Investing In BioMarin (BMRN)

Simply Wall St.

Absci names Ransi Somaratne chief medical officer as Andreas Busch set to retire

Camp4 Therapeutics FY 2025 research and collaboration revenue rises 436.5% to USD 3.5 million

BioMarin Pharmaceutical Is Maintained at Overweight by Barclays

U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials

Amicus Therapeutics Inc. Held Special Stockholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMRN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"Biomarin Pharmaceutical","latestPrice":54.1,"timestamp":1776369600000,"preClose":55.27,"halted":0,"volume":1459410,"hourTrading":{"tag":"盘后","latestPrice":54.42,"preClose":54.1,"latestTime":"19:55 EDT","volume":21736,"amount":1176266.7078,"timestamp":1776383718366,"change":0.32,"changeRate":0.005915,"amplitude":0.010166},"delay":0,"changeRate":-0.021168807671431186,"floatShares":178100339,"shares":192114344,"eps":1.8,"marketStatus":"Not Yet Opened","change":-1.17,"latestTime":"04-16 16:00:00 EDT","open":55.365,"high":55.62,"low":53.79,"amount":79314098.47467001,"amplitude":0.03311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.8,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":932702400000,"exchange":"NASDAQ","adjPreClose":55.27,"preHourTrading":{"tag":"盘前","latestPrice":55.48,"preClose":55.27,"latestTime":"09:25 EDT","volume":112,"amount":6170.760176,"timestamp":1776345910002,"change":0.21,"changeRate":0.0038,"amplitude":0.00778},"postHourTrading":{"tag":"盘后","latestPrice":54.42,"preClose":54.1,"latestTime":"19:55 EDT","volume":21736,"amount":1176266.7078,"timestamp":1776383718366,"change":0.32,"changeRate":0.005915,"amplitude":0.010166},"volumeRatio":1.076032,"impliedVol":0.4001,"impliedVolPercentile":0.506},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","floatShares":178100339,"roa":"5.58%","roe":"5.94%","lyrEps":1.8,"volumeRatio":1.076032,"shares":192114344,"dividePrice":0,"high":55.62,"amplitude":0.03311,"preClose":55.27,"low":53.79,"week52Low":50.76,"pbRate":"1.71","psRate":"3.23","week52High":66.275,"institutionHeld":0.999,"latestPrice":54.1,"eps":1.8,"divideRate":0,"volume":1459410,"delay":0,"ttmEps":1.8,"open":55.365,"prevYearClose":59.43,"prevWeekClose":54.53,"prevMonthClose":56.49,"prevQuarterClose":56.49,"fiveDayClose":56.3,"twentyDayClose":55.43,"sixtyDayClose":56.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-23","symbol":"BMRN","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-10-27","symbol":"BMRN","fiscalQuarterEnding":"2025/09","expectedEps":0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761537600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-08-04","symbol":"BMRN","fiscalQuarterEnding":"2025/06","expectedEps":0.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":1.25},{"market":"US","date":"2025-05-01","symbol":"BMRN","fiscalQuarterEnding":"2025/03","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":0.98},{"market":"US","date":"2025-02-19","symbol":"BMRN","fiscalQuarterEnding":"2024/12","expectedEps":0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.32,"buy":0.48,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.48,"analysts":25,"updateTime":1773115200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMRN","date":"2026-04-15","current":30.055556,"percent":0.334944,"low":-246.955768,"twenty":19.442427,"median":74.573027,"eighty":242.861694,"high":1069.125802,"avg":157.637945,"sd":252.659859,"marketCap":10668176723},"quantilePoints":[{"date":"2021-04-16","current":16.904902,"twenty":-144.931156,"median":-86.817737,"eighty":-27.498326,"marketCap":14437276592},{"date":"2021-04-23","current":16.838842,"twenty":-144.931156,"median":-86.272203,"eighty":-27.151224,"marketCap":14380859669},{"date":"2021-04-30","current":17.900998,"twenty":-144.931156,"median":-85.694758,"eighty":15.913176,"marketCap":14232904679},{"date":"2021-05-07","current":17.874568,"twenty":-144.931156,"median":-85.610935,"eighty":16.023777,"marketCap":14211889902},{"date":"2021-05-14","current":17.681503,"twenty":-144.931156,"median":-85.219763,"eighty":16.210666,"marketCap":14058386140},{"date":"2021-05-21","current":17.950414,"twenty":-144.931156,"median":-84.959558,"eighty":16.297129,"marketCap":14272194951},{"date":"2021-05-28","current":17.766543,"twenty":-144.931156,"median":-84.679572,"eighty":16.395247,"marketCap":14126000892},{"date":"2021-06-04","current":17.902148,"twenty":-144.931156,"median":-84.297713,"eighty":16.432736,"marketCap":14233819010},{"date":"2021-06-11","current":18.862875,"twenty":-144.931156,"median":-84.279085,"eighty":16.501579,"marketCap":14997682966},{"date":"2021-06-18","current":18.823802,"twenty":-144.931156,"median":-84.279085,"eighty":16.577449,"marketCap":14966616728},{"date":"2021-06-25","current":19.488036,"twenty":-144.931156,"median":-84.279085,"eighty":16.648523,"marketCap":15494742764},{"date":"2021-07-02","current":19.644327,"twenty":-144.931156,"median":-84.279085,"eighty":16.690717,"marketCap":15619007714},{"date":"2021-07-09","current":19.219125,"twenty":-144.931156,"median":-84.185949,"eighty":16.765656,"marketCap":15280933954},{"date":"2021-07-16","current":18.120495,"twenty":-144.931156,"median":-83.841344,"eighty":16.854046,"marketCap":14407424455},{"date":"2021-07-23","current":17.706785,"twenty":-144.931156,"median":-83.683013,"eighty":16.951792,"marketCap":14078487823},{"date":"2021-07-30","current":16.8013,"twenty":-144.931156,"median":-83.422231,"eighty":17.027349,"marketCap":14066283248},{"date":"2021-08-06","current":17.110693,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":14325311683},{"date":"2021-08-13","current":16.431784,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13756919692},{"date":"2021-08-20","current":16.455874,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13777088440},{"date":"2021-08-27","current":18.288928,"twenty":-144.931156,"median":-82.965863,"eighty":17.151762,"marketCap":15311746815},{"date":"2021-09-03","current":18.604292,"twenty":-144.931156,"median":-82.965863,"eighty":17.265235,"marketCap":15575774062},{"date":"2021-09-10","current":17.077843,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14297808844},{"date":"2021-09-17","current":17.029662,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14257471348},{"date":"2021-09-24","current":17.213624,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14411487243},{"date":"2021-10-01","current":16.89826,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14147459995},{"date":"2021-10-08","current":17.044992,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14270306006},{"date":"2021-10-15","current":16.620127,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13914602631},{"date":"2021-10-22","current":16.14927,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13520395283},{"date":"2021-10-29","current":913.742979,"twenty":-144.931156,"median":-82.965863,"eighty":17.356508,"marketCap":14544047003},{"date":"2021-11-05","current":967.9689,"twenty":-144.931156,"median":-82.965863,"eighty":17.405709,"marketCap":15407160981},{"date":"2021-11-12","current":942.70851,"twenty":-144.931156,"median":-82.965863,"eighty":17.560148,"marketCap":15005091360},{"date":"2021-11-19","current":1055.053805,"twenty":-144.931156,"median":-82.965863,"eighty":17.678992,"marketCap":16793291407},{"date":"2021-11-26","current":1010.184893,"twenty":-144.931156,"median":-82.965863,"eighty":17.719077,"marketCap":16079112949},{"date":"2021-12-03","current":956.780508,"twenty":-144.931156,"median":-82.965863,"eighty":17.763785,"marketCap":15229075350},{"date":"2021-12-10","current":979.157292,"twenty":-144.931156,"median":-82.965863,"eighty":17.780334,"marketCap":15585246612},{"date":"2021-12-17","current":997.497027,"twenty":-144.931156,"median":-82.965863,"eighty":17.854801,"marketCap":15877160172},{"date":"2021-12-23","current":1051.478133,"twenty":-144.931156,"median":-82.965863,"eighty":17.921454,"marketCap":16736377443},{"date":"2021-12-31","current":1019.0664,"twenty":-144.931156,"median":-82.965863,"eighty":18.068316,"marketCap":16220479893},{"date":"2022-01-07","current":971.77526,"twenty":-144.868574,"median":-82.756306,"eighty":18.102568,"marketCap":15467746814},{"date":"2022-01-14","current":1040.635774,"twenty":-144.868574,"median":-82.756306,"eighty":18.18902,"marketCap":16563799615},{"date":"2022-01-21","current":976.38903,"twenty":-144.868574,"median":-82.756306,"eighty":18.272526,"marketCap":15541184188},{"date":"2022-01-28","current":993.806011,"twenty":-144.868574,"median":-82.756306,"eighty":18.302,"marketCap":15818410273},{"date":"2022-02-04","current":1022.296039,"twenty":-144.868574,"median":-82.756306,"eighty":18.385092,"marketCap":16271886055},{"date":"2022-02-11","current":1048.594527,"twenty":-144.868574,"median":-82.756306,"eighty":18.50696,"marketCap":16690479084},{"date":"2022-02-18","current":978.811259,"twenty":-144.868574,"median":-82.756306,"eighty":18.612353,"marketCap":15579738809},{"date":"2022-02-25","current":-223.863547,"twenty":-146.720429,"median":-83.128851,"eighty":18.645295,"marketCap":14345176092},{"date":"2022-03-04","current":-219.184373,"twenty":-148.717362,"median":-83.543308,"eighty":18.645295,"marketCap":14045334603},{"date":"2022-03-11","current":-218.207922,"twenty":-159.853208,"median":-83.818061,"eighty":18.645295,"marketCap":13982763668},{"date":"2022-03-18","current":-234.549105,"twenty":-161.293219,"median":-83.967078,"eighty":18.645295,"marketCap":15029906670},{"date":"2022-03-25","current":-226.938537,"twenty":-162.185225,"median":-84.288399,"eighty":18.645295,"marketCap":14542221441},{"date":"2022-04-01","current":-227.656515,"twenty":-163.361234,"median":-84.633004,"eighty":18.645295,"marketCap":14588229481},{"date":"2022-04-08","current":-246.955768,"twenty":-164.641244,"median":-84.986921,"eighty":18.645295,"marketCap":15824925610},{"date":"2022-04-14","current":-238.225154,"twenty":-165.041247,"median":-85.857746,"eighty":18.645295,"marketCap":15265467837},{"date":"2022-04-22","current":-232.276832,"twenty":-165.973254,"median":-88.12096,"eighty":18.645295,"marketCap":14884299384},{"date":"2022-04-29","current":382.277246,"twenty":-166.445258,"median":-90.308931,"eighty":18.664196,"marketCap":15041462794},{"date":"2022-05-06","current":372.455987,"twenty":-166.445258,"median":-89.349626,"eighty":18.760072,"marketCap":14655025704},{"date":"2022-05-13","current":365.458317,"twenty":-166.445258,"median":-89.349626,"eighty":18.859197,"marketCap":14379688400},{"date":"2022-05-20","current":374.814577,"twenty":-166.445258,"median":-89.349626,"eighty":18.955948,"marketCap":14747829142},{"date":"2022-05-27","current":380.691624,"twenty":-166.445258,"median":-89.349626,"eighty":19.066512,"marketCap":14979073327},{"date":"2022-06-03","current":364.329924,"twenty":-166.445258,"median":-89.349626,"eighty":19.178673,"marketCap":14335289516},{"date":"2022-06-10","current":352.998976,"twenty":-166.445258,"median":-89.349626,"eighty":19.261875,"marketCap":13889450727},{"date":"2022-06-17","current":357.700614,"twenty":-166.445258,"median":-89.349626,"eighty":19.519294,"marketCap":14074446075},{"date":"2022-06-24","current":408.337255,"twenty":-166.509258,"median":-86.272203,"eighty":107.93637,"marketCap":16066845973},{"date":"2022-07-01","current":399.545192,"twenty":-166.509258,"median":-84.809963,"eighty":110.39574,"marketCap":15720904673},{"date":"2022-07-08","current":418.539809,"twenty":-166.509258,"median":-84.754081,"eighty":111.051374,"marketCap":16468285878},{"date":"2022-07-15","current":409.418632,"twenty":-166.509258,"median":-83.152135,"eighty":111.935442,"marketCap":16109394903},{"date":"2022-07-22","current":400.720602,"twenty":-166.509258,"median":-83.077626,"eighty":112.591077,"marketCap":15767153510},{"date":"2022-07-29","current":404.575945,"twenty":-166.509258,"median":-81.708522,"eighty":113.113211,"marketCap":15918849695},{"date":"2022-08-05","current":327.838991,"twenty":-166.509258,"median":-34.536978,"eighty":114.110012,"marketCap":17726254245},{"date":"2022-08-12","current":325.272938,"twenty":-166.509258,"median":-34.536978,"eighty":114.976279,"marketCap":17587507734},{"date":"2022-08-19","current":318.464838,"twenty":-166.509258,"median":-34.536978,"eighty":115.685314,"marketCap":17219393812},{"date":"2022-08-26","current":312.187472,"twenty":-166.509258,"median":-34.536978,"eighty":116.907582,"marketCap":16879976635},{"date":"2022-09-02","current":307.488024,"twenty":-166.509258,"median":-34.536978,"eighty":117.883617,"marketCap":16625877437},{"date":"2022-09-09","current":318.773561,"twenty":-166.509258,"median":-34.536978,"eighty":141.162306,"marketCap":17236086460},{"date":"2022-09-16","current":302.58276,"twenty":-166.509258,"median":-34.536978,"eighty":148.167383,"marketCap":16360649808},{"date":"2022-09-23","current":291.022801,"twenty":-166.509258,"median":-34.536978,"eighty":150.289725,"marketCap":15735602876},{"date":"2022-09-30","current":290.782684,"twenty":-166.509258,"median":-34.536978,"eighty":152.726136,"marketCap":15722619705},{"date":"2022-10-07","current":302.376944,"twenty":-166.509258,"median":-34.536978,"eighty":167.017841,"marketCap":16349521376},{"date":"2022-10-14","current":299.289715,"twenty":-166.509258,"median":-34.536978,"eighty":168.933976,"marketCap":16182594895},{"date":"2022-10-21","current":308.757218,"twenty":-166.509258,"median":-34.536978,"eighty":170.628042,"marketCap":16694502768},{"date":"2022-10-28","current":192.178834,"twenty":-166.509258,"median":-34.536978,"eighty":175.146289,"marketCap":16126110354},{"date":"2022-11-04","current":182.699459,"twenty":-166.509258,"median":-34.536978,"eighty":176.471621,"marketCap":15330676998},{"date":"2022-11-11","current":181.968573,"twenty":-166.509258,"median":-34.536978,"eighty":178.346579,"marketCap":15269346856},{"date":"2022-11-18","current":195.589638,"twenty":-166.509258,"median":-34.536978,"eighty":182.260927,"marketCap":16412317683},{"date":"2022-11-25","current":214.659129,"twenty":-166.509258,"median":-34.536978,"eighty":187.341695,"marketCap":18012476841},{"date":"2022-12-02","current":233.795065,"twenty":-166.509258,"median":-34.536978,"eighty":190.997361,"marketCap":19618211467},{"date":"2022-12-09","current":226.641237,"twenty":-166.509258,"median":-34.536978,"eighty":192.536436,"marketCap":19017919471},{"date":"2022-12-16","current":240.594523,"twenty":-166.509258,"median":-34.14536,"eighty":193.90401,"marketCap":20188767636},{"date":"2022-12-23","current":231.093,"twenty":-166.509258,"median":-33.835795,"eighty":195.798534,"marketCap":19391475791},{"date":"2022-12-30","current":229.210413,"twenty":-166.509258,"median":15.910621,"eighty":196.943179,"marketCap":19233504213},{"date":"2023-01-06","current":240.771708,"twenty":-166.509258,"median":15.99843,"eighty":199.747589,"marketCap":20203635549},{"date":"2023-01-13","current":249.653085,"twenty":-166.509258,"median":16.07919,"eighty":201.466427,"marketCap":20948889698},{"date":"2023-01-20","current":245.289915,"twenty":-166.509258,"median":16.188691,"eighty":202.812136,"marketCap":20582767336},{"date":"2023-01-27","current":259.730459,"twenty":-166.509258,"median":16.239185,"eighty":206.755441,"marketCap":21794502262},{"date":"2023-02-03","current":248.501386,"twenty":-166.509258,"median":16.333756,"eighty":220.240444,"marketCap":20852248263},{"date":"2023-02-10","current":242.432813,"twenty":-166.509258,"median":16.413891,"eighty":226.49506,"marketCap":20343022235},{"date":"2023-02-17","current":239.885785,"twenty":-166.509258,"median":16.442734,"eighty":229.440754,"marketCap":20129295983},{"date":"2023-02-24","current":226.065387,"twenty":-166.509258,"median":16.476957,"eighty":230.229225,"marketCap":18969598754},{"date":"2023-03-03","current":133.346847,"twenty":-166.509258,"median":16.516158,"eighty":230.229225,"marketCap":18876712940},{"date":"2023-03-10","current":119.234744,"twenty":-166.509258,"median":16.567292,"eighty":230.229225,"marketCap":16878989664},{"date":"2023-03-17","current":120.789579,"twenty":-166.509258,"median":16.617476,"eighty":230.229225,"marketCap":17099093629},{"date":"2023-03-24","current":119.564159,"twenty":-166.509258,"median":16.650384,"eighty":230.229225,"marketCap":16925621860},{"date":"2023-03-31","current":128.128926,"twenty":-166.445258,"median":16.685656,"eighty":229.9413,"marketCap":18138058956},{"date":"2023-04-06","current":127.246097,"twenty":-166.445258,"median":16.720301,"eighty":229.9413,"marketCap":18013084670},{"date":"2023-04-14","current":129.578349,"twenty":-166.509258,"median":16.77077,"eighty":230.229225,"marketCap":18343240618},{"date":"2023-04-21","current":127.575511,"twenty":-166.509258,"median":16.817229,"eighty":230.229225,"marketCap":18059716866},{"date":"2023-04-28","current":242.180022,"twenty":-166.509258,"median":16.855933,"eighty":231.407502,"marketCap":17343722249},{"date":"2023-05-05","current":250.17182,"twenty":-166.509258,"median":16.91578,"eighty":235.380867,"marketCap":17916054913},{"date":"2023-05-12","current":250.014562,"twenty":-166.573259,"median":16.941683,"eighty":237.019824,"marketCap":17904792857},{"date":"2023-05-19","current":241.732289,"twenty":-166.637259,"median":16.967171,"eighty":239.8282,"marketCap":17311657880},{"date":"2023-05-26","current":232.558885,"twenty":-166.637259,"median":17.014711,"eighty":240.585664,"marketCap":16654704583},{"date":"2023-05-30","current":231.916747,"twenty":-166.637259,"median":17.029662,"eighty":240.585664,"marketCap":16608717852},{"date":"2023-06-09","current":241.810918,"twenty":-166.73726,"median":17.061278,"eighty":241.008901,"marketCap":17317288908},{"date":"2023-06-16","current":251.194,"twenty":-166.74926,"median":17.112883,"eighty":241.385297,"marketCap":17989258281},{"date":"2023-06-23","current":250.591176,"twenty":-166.76126,"median":17.196104,"eighty":241.856963,"marketCap":17946087064},{"date":"2023-06-30","current":233.08308,"twenty":-166.76126,"median":17.241,"eighty":242.23058,"marketCap":16692244772},{"date":"2023-07-07","current":224.355242,"twenty":-166.76126,"median":17.308262,"eighty":242.23058,"marketCap":16067200635},{"date":"2023-07-14","current":224.643549,"twenty":-166.76126,"median":17.371372,"eighty":242.23058,"marketCap":16087847738},{"date":"2023-07-21","current":229.439928,"twenty":-166.76126,"median":17.48024,"eighty":242.23058,"marketCap":16431340462},{"date":"2023-07-28","current":226.871375,"twenty":-166.76126,"median":17.641098,"eighty":242.23058,"marketCap":16247393539},{"date":"2023-08-04","current":165.119407,"twenty":-166.76126,"median":17.695247,"eighty":242.23058,"marketCap":16510454583},{"date":"2023-08-11","current":171.085084,"twenty":-166.76126,"median":17.746561,"eighty":242.23058,"marketCap":17106968613},{"date":"2023-08-18","current":168.243389,"twenty":-166.76126,"median":17.778035,"eighty":242.23058,"marketCap":16822824706},{"date":"2023-08-25","current":175.281759,"twenty":-166.76126,"median":17.843539,"eighty":242.23058,"marketCap":17526598357},{"date":"2023-09-01","current":171.969585,"twenty":-166.76126,"median":17.901573,"eighty":242.23058,"marketCap":17195410756},{"date":"2023-09-08","current":170.162944,"twenty":-166.76126,"median":18.020515,"eighty":242.23058,"marketCap":17014762974},{"date":"2023-09-15","current":165.006492,"twenty":-166.76126,"median":18.09038,"eighty":242.23058,"marketCap":16499164096},{"date":"2023-09-22","current":162.352988,"twenty":-166.76126,"median":18.138595,"eighty":242.23058,"marketCap":16233837666},{"date":"2023-09-29","current":167.961101,"twenty":-166.76126,"median":18.255988,"eighty":242.23058,"marketCap":16794598490},{"date":"2023-10-06","current":164.272544,"twenty":-166.76126,"median":18.295251,"eighty":242.23058,"marketCap":16425775935},{"date":"2023-10-13","current":162.861106,"twenty":-166.76126,"median":18.372948,"eighty":242.23058,"marketCap":16284644855},{"date":"2023-10-20","current":155.427533,"twenty":-166.76126,"median":18.480739,"eighty":242.23058,"marketCap":15541354502},{"date":"2023-10-27","current":154.260745,"twenty":-166.76126,"median":18.544458,"eighty":242.382255,"marketCap":15424686142},{"date":"2023-11-03","current":102.060294,"twenty":-166.76126,"median":18.649124,"eighty":242.382255,"marketCap":15005006530},{"date":"2023-11-10","current":107.264835,"twenty":-166.76126,"median":18.746862,"eighty":242.382255,"marketCap":15770183276},{"date":"2023-11-17","current":111.736338,"twenty":-166.76126,"median":18.837592,"eighty":242.382255,"marketCap":16427588192},{"date":"2023-11-24","current":112.991947,"twenty":-166.76126,"median":18.922633,"eighty":242.382255,"marketCap":16612189000},{"date":"2023-12-01","current":116.69471,"twenty":-166.76126,"median":18.980092,"eighty":242.382255,"marketCap":17156573014},{"date":"2023-12-08","current":121.64027,"twenty":-166.76126,"median":19.115548,"eighty":242.331697,"marketCap":17883674154},{"date":"2023-12-15","current":125.073975,"twenty":-166.76126,"median":19.224871,"eighty":242.331697,"marketCap":18388500853},{"date":"2023-12-22","current":121.922141,"twenty":-166.76126,"median":19.421383,"eighty":242.331697,"marketCap":17925115152},{"date":"2023-12-29","current":124.446171,"twenty":-166.76126,"median":97.655587,"eighty":242.382255,"marketCap":18296200449},{"date":"2024-01-05","current":125.21491,"twenty":-166.76126,"median":106.724665,"eighty":242.432813,"marketCap":18409221351},{"date":"2024-01-12","current":122.998377,"twenty":-166.76126,"median":107.662485,"eighty":242.432813,"marketCap":18083344416},{"date":"2024-01-19","current":118.552498,"twenty":-166.79726,"median":109.532617,"eighty":242.575773,"marketCap":17429706862},{"date":"2024-01-26","current":116.91252,"twenty":-166.76126,"median":110.397223,"eighty":242.432813,"marketCap":17188595603},{"date":"2024-02-02","current":113.696625,"twenty":-166.76126,"median":111.153724,"eighty":242.432813,"marketCap":16715791494},{"date":"2024-02-09","current":112.940697,"twenty":-166.76126,"median":111.821225,"eighty":242.432813,"marketCap":16604654273},{"date":"2024-02-16","current":113.132882,"twenty":-166.76126,"median":112.099749,"eighty":242.432813,"marketCap":16632909499},{"date":"2024-02-23","current":101.214924,"twenty":-166.70126,"median":112.294622,"eighty":242.432813,"marketCap":16968175915},{"date":"2024-03-01","current":97.103598,"twenty":-165.901253,"median":112.199476,"eighty":242.382255,"marketCap":16278932666},{"date":"2024-03-08","current":96.664673,"twenty":-164.837246,"median":112.199476,"eighty":242.382255,"marketCap":16205349173},{"date":"2024-03-15","current":94.976502,"twenty":-164.11324,"median":112.199476,"eighty":242.382255,"marketCap":15922335740},{"date":"2024-03-22","current":94.661377,"twenty":-162.221226,"median":112.199476,"eighty":242.382255,"marketCap":15869506566},{"date":"2024-03-28","current":99.72589,"twenty":-162.081225,"median":112.199476,"eighty":242.382255,"marketCap":16718546865},{"date":"2024-04-05","current":97.790121,"twenty":-160.981216,"median":112.294622,"eighty":242.432813,"marketCap":16394024795},{"date":"2024-04-12","current":103.533211,"twenty":-131.648601,"median":112.294622,"eighty":242.432813,"marketCap":17356825158},{"date":"2024-04-19","current":101.959724,"twenty":-125.404689,"median":112.294622,"eighty":242.432813,"marketCap":17093037852},{"date":"2024-04-26","current":75.899547,"twenty":-124.450186,"median":112.199476,"eighty":242.382255,"marketCap":15593941332},{"date":"2024-05-03","current":77.447263,"twenty":-123.068927,"median":112.199476,"eighty":242.382255,"marketCap":15911927491},{"date":"2024-05-10","current":75.524945,"twenty":-121.619256,"median":112.199476,"eighty":242.382255,"marketCap":15516977501},{"date":"2024-05-17","current":71.135034,"twenty":-119.850332,"median":112.199476,"eighty":242.382255,"marketCap":14615048436},{"date":"2024-05-24","current":70.146149,"twenty":-118.560287,"median":112.199476,"eighty":242.382255,"marketCap":14411877047},{"date":"2024-05-31","current":69.37907,"twenty":-117.48525,"median":112.199476,"eighty":242.382255,"marketCap":14254276811},{"date":"2024-06-07","current":74.573027,"twenty":-116.644766,"median":112.199476,"eighty":242.382255,"marketCap":15321401304},{"date":"2024-06-14","current":77.179248,"twenty":-111.14579,"median":112.199476,"eighty":242.382255,"marketCap":15856862348},{"date":"2024-06-21","current":77.42878,"twenty":-109.718923,"median":112.294622,"eighty":242.432813,"marketCap":15908129895},{"date":"2024-06-28","current":76.088702,"twenty":-105.956293,"median":112.294622,"eighty":242.432813,"marketCap":15632804180},{"date":"2024-07-05","current":75.275413,"twenty":-104.685795,"median":112.294622,"eighty":242.432813,"marketCap":15465709954},{"date":"2024-07-12","current":78.574777,"twenty":15.974047,"median":112.294622,"eighty":242.432813,"marketCap":16143580851},{"date":"2024-07-19","current":77.715279,"twenty":16.07669,"median":112.294622,"eighty":242.432813,"marketCap":15966992634},{"date":"2024-07-26","current":78.177375,"twenty":16.188691,"median":112.294622,"eighty":242.432813,"marketCap":16061932535},{"date":"2024-08-02","current":77.81694,"twenty":16.239185,"median":112.294622,"eighty":242.432813,"marketCap":15987879412},{"date":"2024-08-09","current":65.768733,"twenty":16.333756,"median":112.294622,"eighty":242.432813,"marketCap":16875533342},{"date":"2024-08-16","current":66.429091,"twenty":16.413891,"median":112.294622,"eighty":242.432813,"marketCap":17044974053},{"date":"2024-08-23","current":66.792659,"twenty":16.442734,"median":112.294622,"eighty":242.432813,"marketCap":17138261636},{"date":"2024-08-30","current":67.67561,"twenty":16.477433,"median":112.294622,"eighty":242.432813,"marketCap":17364817194},{"date":"2024-09-06","current":62.385323,"twenty":16.516158,"median":112.294622,"eighty":242.432813,"marketCap":16007387673},{"date":"2024-09-13","current":62.993743,"twenty":16.567292,"median":112.294622,"eighty":242.432813,"marketCap":16163501587},{"date":"2024-09-20","current":52.450267,"twenty":16.617476,"median":112.294622,"eighty":242.432813,"marketCap":13458161687},{"date":"2024-09-27","current":52.36865,"twenty":16.650384,"median":112.294622,"eighty":242.432813,"marketCap":13437219576},{"date":"2024-10-04","current":51.574736,"twenty":16.689865,"median":112.294622,"eighty":242.432813,"marketCap":13233509957},{"date":"2024-10-11","current":52.197996,"twenty":16.740578,"median":112.294622,"eighty":242.432813,"marketCap":13393431527},{"date":"2024-10-18","current":52.019922,"twenty":16.78674,"median":112.294622,"eighty":242.432813,"marketCap":13347739650},{"date":"2024-10-25","current":51.737971,"twenty":16.823799,"median":112.294622,"eighty":242.432813,"marketCap":13275394178},{"date":"2024-11-01","current":39.383132,"twenty":16.89388,"median":112.294622,"eighty":242.432813,"marketCap":12692828865},{"date":"2024-11-08","current":39.661061,"twenty":16.92235,"median":112.294622,"eighty":242.432813,"marketCap":12782402883},{"date":"2024-11-15","current":37.502676,"twenty":16.946441,"median":112.294622,"eighty":242.432813,"marketCap":12086774874},{"date":"2024-11-22","current":37.9994,"twenty":16.977101,"median":112.294622,"eighty":242.432813,"marketCap":12246864608},{"date":"2024-11-29","current":39.046069,"twenty":17.029662,"median":112.294622,"eighty":242.432813,"marketCap":12584196546},{"date":"2024-12-06","current":39.465919,"twenty":17.060322,"median":112.294622,"eighty":242.432813,"marketCap":12719510487},{"date":"2024-12-13","current":39.034242,"twenty":17.110693,"median":112.294622,"eighty":242.432813,"marketCap":12580384886},{"date":"2024-12-20","current":38.827274,"twenty":17.196104,"median":112.294622,"eighty":242.432813,"marketCap":12513680830},{"date":"2024-12-27","current":39.55462,"twenty":17.220194,"median":112.294622,"eighty":242.432813,"marketCap":12748097940},{"date":"2025-01-03","current":39.519139,"twenty":17.307796,"median":112.294622,"eighty":242.432813,"marketCap":12736662959},{"date":"2025-01-10","current":39.844375,"twenty":17.365255,"median":112.389767,"eighty":242.575773,"marketCap":12841483618},{"date":"2025-01-17","current":36.385046,"twenty":17.450199,"median":112.389767,"eighty":242.575773,"marketCap":11726572974},{"date":"2025-01-24","current":36.503314,"twenty":17.562906,"median":112.389767,"eighty":242.575773,"marketCap":11764689577},{"date":"2025-01-31","current":37.467195,"twenty":17.680666,"median":112.389767,"eighty":242.575773,"marketCap":12075339893},{"date":"2025-02-07","current":37.804258,"twenty":17.732712,"median":112.389767,"eighty":242.575773,"marketCap":12183972212},{"date":"2025-02-14","current":38.34829,"twenty":17.773898,"median":112.389767,"eighty":242.575773,"marketCap":12359308587},{"date":"2025-02-21","current":30.500615,"twenty":17.780334,"median":112.389767,"eighty":242.575773,"marketCap":13019462069},{"date":"2025-02-28","current":31.803699,"twenty":17.85572,"median":112.389767,"eighty":242.575773,"marketCap":13575695020},{"date":"2025-03-07","current":32.281916,"twenty":18.006035,"median":112.415391,"eighty":242.718733,"marketCap":13779826465},{"date":"2025-03-14","current":31.034975,"twenty":18.081882,"median":112.415391,"eighty":242.718733,"marketCap":13247558490},{"date":"2025-03-21","current":31.839453,"twenty":18.118783,"median":112.415391,"eighty":242.718733,"marketCap":13590957184},{"date":"2025-03-28","current":31.92884,"twenty":18.238419,"median":112.415391,"eighty":242.718733,"marketCap":13629112594},{"date":"2025-04-04","current":26.932137,"twenty":18.288668,"median":112.415391,"eighty":242.718733,"marketCap":11496225153},{"date":"2025-04-11","current":25.524756,"twenty":18.312181,"median":112.389767,"eighty":242.575773,"marketCap":10895471939},{"date":"2025-04-17","current":26.580426,"twenty":18.41352,"median":112.389767,"eighty":242.575773,"marketCap":11346094238},{"date":"2025-04-25","current":28.435711,"twenty":18.53764,"median":112.415391,"eighty":242.718733,"marketCap":12138038961},{"date":"2025-05-02","current":22.707063,"twenty":18.58729,"median":112.139927,"eighty":242.718733,"marketCap":11895844499},{"date":"2025-05-09","current":21.546635,"twenty":18.58729,"median":111.745407,"eighty":242.718733,"marketCap":11287915641},{"date":"2025-05-16","current":21.696722,"twenty":18.58729,"median":111.057308,"eighty":242.718733,"marketCap":11366543664},{"date":"2025-05-23","current":21.235479,"twenty":18.58729,"median":110.374974,"eighty":242.718733,"marketCap":11124906326},{"date":"2025-05-30","current":21.433154,"twenty":18.58729,"median":109.878551,"eighty":242.718733,"marketCap":11228465185},{"date":"2025-06-06","current":20.232458,"twenty":18.58729,"median":107.994221,"eighty":242.718733,"marketCap":10599441004},{"date":"2025-06-13","current":20.968251,"twenty":18.58729,"median":106.858165,"eighty":242.718733,"marketCap":10984910091},{"date":"2025-06-20","current":20.221476,"twenty":18.578788,"median":103.589811,"eighty":242.861694,"marketCap":10593687734},{"date":"2025-06-27","current":19.804161,"twenty":18.578788,"median":102.118204,"eighty":242.861694,"marketCap":10375063476},{"date":"2025-07-03","current":21.048785,"twenty":18.578788,"median":101.959724,"eighty":242.861694,"marketCap":11027100737},{"date":"2025-07-11","current":21.531992,"twenty":18.578788,"median":100.329636,"eighty":242.861694,"marketCap":11280244615},{"date":"2025-07-18","current":21.367262,"twenty":18.578788,"median":98.296572,"eighty":242.861694,"marketCap":11193945566},{"date":"2025-07-25","current":21.876094,"twenty":18.578788,"median":97.790121,"eighty":242.861694,"marketCap":11460513740},{"date":"2025-08-01","current":21.176908,"twenty":18.578788,"median":97.373705,"eighty":242.861694,"marketCap":11094222220},{"date":"2025-08-08","current":17.371388,"twenty":18.507812,"median":96.664673,"eighty":242.861694,"marketCap":11417188175},{"date":"2025-08-15","current":16.944845,"twenty":18.385518,"median":95.392918,"eighty":242.861694,"marketCap":11136846858},{"date":"2025-08-22","current":16.965296,"twenty":18.302426,"median":84.240461,"eighty":242.861694,"marketCap":11150287880},{"date":"2025-08-29","current":16.851356,"twenty":18.272864,"median":78.68568,"eighty":242.861694,"marketCap":11075402185},{"date":"2025-09-05","current":16.579654,"twenty":18.18902,"median":78.265173,"eighty":243.004654,"marketCap":10896828606},{"date":"2025-09-12","current":16.334246,"twenty":18.103027,"median":78.177375,"eighty":242.861694,"marketCap":10735536341},{"date":"2025-09-19","current":16.109289,"twenty":18.073255,"median":77.853908,"eighty":242.861694,"marketCap":10587685099},{"date":"2025-09-26","current":15.373065,"twenty":17.971559,"median":77.548924,"eighty":242.861694,"marketCap":10103808304},{"date":"2025-10-03","current":16.234914,"twenty":17.854801,"median":77.170006,"eighty":242.861694,"marketCap":10670251377},{"date":"2025-10-10","current":15.732412,"twenty":17.780334,"median":76.412169,"eighty":242.861694,"marketCap":10339986263},{"date":"2025-10-17","current":15.469475,"twenty":17.763785,"median":75.98704,"eighty":242.861694,"marketCap":10167173122},{"date":"2025-10-24","current":15.936919,"twenty":17.724471,"median":75.626606,"eighty":242.861694,"marketCap":10474396484},{"date":"2025-10-31","current":19.162817,"twenty":17.719077,"median":74.776349,"eighty":242.861694,"marketCap":9972655597},{"date":"2025-11-07","current":19.136976,"twenty":17.728872,"median":74.573027,"eighty":242.861694,"marketCap":9959207592},{"date":"2025-11-14","current":20.015564,"twenty":17.770221,"median":74.573027,"eighty":242.861694,"marketCap":10416439731},{"date":"2025-11-21","current":19.373235,"twenty":17.797802,"median":74.573027,"eighty":242.861694,"marketCap":10082160773},{"date":"2025-11-28","current":20.646818,"twenty":17.854801,"median":74.573027,"eighty":242.861694,"marketCap":10744955259},{"date":"2025-12-05","current":19.867902,"twenty":17.971559,"median":74.573027,"eighty":242.861694,"marketCap":10339593994},{"date":"2025-12-12","current":19.561504,"twenty":18.073255,"median":74.573027,"eighty":242.861694,"marketCap":10180139088},{"date":"2025-12-19","current":19.177583,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":9980340170},{"date":"2025-12-26","current":22.208342,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11557598935},{"date":"2026-01-02","current":21.93886,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11417355463},{"date":"2026-01-09","current":22.278482,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11594100660},{"date":"2026-01-16","current":20.329345,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10579736924},{"date":"2026-01-23","current":21.108262,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10985098189},{"date":"2026-01-30","current":21.038122,"twenty":18.193189,"median":74.573027,"eighty":242.861694,"marketCap":10948596464},{"date":"2026-02-06","current":21.097187,"twenty":18.283472,"median":74.573027,"eighty":242.861694,"marketCap":10979334759},{"date":"2026-02-13","current":22.127128,"twenty":18.296023,"median":74.573027,"eighty":242.861694,"marketCap":11515333779},{"date":"2026-02-20","current":23.411787,"twenty":18.447486,"median":74.573027,"eighty":242.861694,"marketCap":12183891696},{"date":"2026-02-27","current":33.681355,"twenty":18.682221,"median":74.573027,"eighty":242.861694,"marketCap":11751458561},{"date":"2026-03-06","current":33.387769,"twenty":18.886778,"median":74.573027,"eighty":242.861694,"marketCap":11649025854},{"date":"2026-03-13","current":32.560929,"twenty":19.024071,"median":74.573027,"eighty":242.861694,"marketCap":11360540816},{"date":"2026-03-20","current":30.333976,"twenty":19.128116,"median":74.573027,"eighty":242.861694,"marketCap":10583554445},{"date":"2026-03-27","current":30.620613,"twenty":19.179593,"median":74.573027,"eighty":242.861694,"marketCap":10683562592},{"date":"2026-04-02","current":31.552185,"twenty":19.246563,"median":74.573027,"eighty":242.861694,"marketCap":11008589069},{"date":"2026-04-10","current":31.034033,"twenty":19.403778,"median":74.573027,"eighty":242.861694,"marketCap":10827805111},{"date":"2026-04-15","current":30.576515,"twenty":19.442427,"median":74.573027,"eighty":242.861694,"marketCap":10668176723}],"updateTime":1776378592959},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMRN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626165909","title":"Is It Time To Reassess BioMarin Pharmaceutical (BMRN) After A 42.7% Three-Year Share Price Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2626165909","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626165909?lang=en_us&edition=fundamental","pubTime":"2026-04-10 11:39","pubTimestamp":1775792366,"startTime":"0","endTime":"0","summary":"Investors may be wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, or if the market is overlooking something important.\nOver the past week the stock is up 1.4%, while returns over 1 year sit at 0.0% and over 3 years at a 42.7% decline. This performance can prompt questions about how the market is currently viewing its potential and risks.\nRecent coverage around BioMarin has focused on its position within the biotech space and how investors...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/is-it-time-to-reassess-biomarin-pharmaceutical-bmrn-after-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/is-it-time-to-reassess-biomarin-pharmaceutical-bmrn-after-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z3581.USD","BK4139","IE00B19Z3B42.SGD","DCF","BK4566","BMRN","IE00B7SZLL34.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626971096","title":"RBC Capital Sticks to Their Hold Rating for BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626971096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626971096?lang=en_us&edition=fundamental","pubTime":"2026-04-09 09:57","pubTimestamp":1775699829,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Hold rating on BioMarin Pharmaceutical on April 7 and set a price target of $66.00. The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625393234","title":"BioMarin Pharmaceutical Secures European Regulatory Approval for Amicus Therapeutics Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2625393234","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625393234?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559602,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical's  proposed acquisition of Amicus Therapeutics  has been approved by the European Commission, the regulator said Tuesday.The regulator said the pending transaction raised no competition concerns.Under the deal announced in December, BioMarin will acquire Amicus for $14.50 per share in cash, valuing the company at about $4.8 billion.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z3581.USD","LU2065171402.SGD","FOLD","BK4139","IE0002270589.USD","BK4566","LU2065170008.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3B42.SGD","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535523","title":"What BioMarin Pharmaceutical (BMRN)'s Voxzogo Trial Stops and Mixed Safety Data Mean For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535523","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623535523?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:10","pubTimestamp":1774969846,"startTime":"0","endTime":"0","summary":"Recently, BioMarin Pharmaceutical discontinued three Phase 2 Voxzogo studies following safety concerns, while simultaneously reporting encouraging clinical and real-world outcomes for the drug in other settings.\nThe company and analysts now suggest that Voxzogo’s safety issues may be limited to specific uses, with BioMarin’s broader outlook increasingly supported by its wider rare-disease portfolio.\nNow we’ll explore how the Voxzogo safety-driven trial discontinuations, alongside positive...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/what-biomarin-pharmaceutical-bmrns-voxzogo-trial-stops-and-m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/what-biomarin-pharmaceutical-bmrns-voxzogo-trial-stops-and-m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B7SZLL34.SGD","BK4566","IE00B19Z3581.USD","BMRN","IE00B19Z3B42.SGD","BK4139","IE0002270589.USD","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823238","title":"Exploring High Growth Tech Stocks In The US Market March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823238","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823238?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:08","pubTimestamp":1774609703,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/exploring-high-growth-tech-stocks-in-the-us-market-march-202-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-knsa/kiniksa-pharmaceuticals-international/news/exploring-high-growth-tech-stocks-in-the-us-market-march-202-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","BMRN","IE0002270589.USD","IE00B7SZLL34.SGD","KVYO","BK4023","BK4139","IE00B19Z3581.USD","KNSA","IE00B19Z3B42.SGD","BK4566","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620601314","title":"Wells Fargo says buy BioMarin shares amid Phase 2 trial discontinuation weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2620601314","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620601314?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:55","pubTimestamp":1773680111,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) announced Monday the discontinuation of three Voxzogo Phase 2 studies in Turner Syndrome, SHOX-difficiency, and ACAN-difficiency, d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wells-fargo-says-buy-biomarin-shares-amid-phase-2-trial-discontinuation-weakness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wells-fargo-says-buy-biomarin-shares-amid-phase-2-trial-discontinuation-weakness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0640476718.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4207","LU0070302665.USD","LU0130102774.USD","LU0208291251.USD","LU0980610538.SGD","LU1814569148.SGD","BK4504","LU0787776722.HKD","BK4501","BK4559","LU0256863811.USD","LU0175139822.USD","LU0942090050.USD","LU0417517546.SGD","BK4585","LU1035773651.USD","LU1074936037.SGD","LU0310800965.SGD","IE0002270589.USD","LU1363072403.SGD","LU1267930573.SGD","IE000M9KFDE8.USD","LU1506573853.SGD","BMRN","BK4566","LU2361044865.SGD","LU1267930227.SGD","LU0251142724.SGD","LU1668664300.SGD","LU0211328371.USD","LU0128525929.USD","LU0477156953.USD","LU0868494708.USD","LU0130517989.USD","IE00B7SZLL34.SGD","LU1280957306.USD","LU0052756011.USD","LU0742534661.SGD","LU1791807156.HKD","LU0072461881.USD","LU0310799852.SGD","LU2461242641.AUD","LU0251131958.USD","LU0971096721.USD","LU0149725797.USD","LU2236285917.USD","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619346849","title":"BioMarin halts Phase 2 VOXZOGO dosing and enrollment in Turner syndrome, SHOX-deficiency and ACAN-deficiency trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2619346849","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619346849?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:32","pubTimestamp":1773664376,"startTime":"0","endTime":"0","summary":"BioMarin discontinued dosing and enrollment in its Phase 2 VOXZOGO trials for Turner syndrome, SHOX-deficiency and ACAN-deficiency after several slipped capital femoral epiphysis events occurred in two investigator-sponsored trials.SCFE events have not been observed in BioMarin’s Phase 2 trials in these conditions and have not been reported among more than 5,000 infants and children who received VOXZOGO for achondroplasia.BioMarin cited 10 years of clinical research and more than 10,000 patient-years of VOXZOGO safety data from clinical studies and post-marketing surveillance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL8kc33z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4566","BMRN","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619689114","title":"Biomarin: Decision to Discontinue Following Occurrence of Several Slipped Capital Femoral Epiphysis Events in 2 Ongoing Investigator-Sponsored Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2619689114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619689114?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:31","pubTimestamp":1773664264,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040K7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4566","BMRN","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619346894","title":"Biomarin Pharmaceutical - Phase 2 Canopy Trials of Voxzogo in Noonan Syndrome, Idiopathic Short Stature to Continue - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2619346894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619346894?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:31","pubTimestamp":1773664264,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040K7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","BMRN","IE00B19Z3581.USD","BK4139","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132439","title":"BioMarin reports VOXZOGO trial data showing 4.7 cm additional height gain at four years in children with achondroplasia treated before age 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132439","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132439?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:09","pubTimestamp":1773320995,"startTime":"0","endTime":"0","summary":"BioMarin reports VOXZOGO trial data showing 4.7 cm additional height gain at four years in children with achondroplasia treated before age 2. BioMarin reported new data from studies of VOXZOGO  in children with achondroplasia that will be presented at the 2026 ACMG Annual Clinical Genetics Meeting. In a study of children who started treatment before age 2, the least squares mean difference in upper-to-lower body segment ratio versus untreated children was 0.33 at year 1  and 0.53 at year 4 . Among more than 20 children who began VOXZOGO between 0.5 to <2 years of age, average additional height gain after four years was 4.7 cm  versus untreated children. BioMarin also cited real-world findings in Japan showing mean height change from baseline of 9.91 cm at 12 months and 15.62 cm at 24 months in children under age 2 receiving VOXZOGO.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL6VK03b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0002270589.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949483","title":"BioMarin Pharmaceutical Is Maintained at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949483?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:08","pubTimestamp":1773227280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMRN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 07:08 ET (11:08 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3581.USD","BK4566","IE00B19Z3B42.SGD","BMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618468949","title":"Biomarin Pharmaceutical Inc : Bofa Global Research Cuts Price Objective to $85.00 From $97.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2618468949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618468949?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:38","pubTimestamp":1773225535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ0CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BMRN","IE00B7SZLL34.SGD","BK4566","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618094662","title":"BioMarin price target lowered to $85 from $97 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2618094662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618094662?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:36","pubTimestamp":1773225370,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on BioMarin (BMRN) to $85 from $97 and keeps a Buy rating on the shares. The firm, which updated its outlook f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarin-price-target-lowered-to-85-from-97-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarin-price-target-lowered-to-85-from-97-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B19Z3B42.SGD","IE0002270589.USD","BMRN","IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618916466","title":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618916466?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:10","pubTimestamp":1773213002,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, OracleMarch 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXX","CNC","CLYM","HIMS","CHH","ADC","DBI","HIMZ","BKNU","HAS","ABM","HMYY","EPRT","SJM","CASY","AVAV","DXCM","HIYY","HLT","REGN","ABT","H","HAE","MET","NKE","ORCX","ORCU","BLND","CRBG","HWM","ORCL","UEC","ALMS","APYX","RNA","AVR","CDW","EXPE","ORCS","FICO","HOG","GEHC","BKNG","BMRN","HIMY","ELV","PGNY","BSX","T","CNCG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618049999","title":"PALYNZIQ Pediatric Label Expansion Under REMS Might Change The Case For Investing In BioMarin (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618049999","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618049999?lang=en_us&edition=fundamental","pubTime":"2026-03-11 09:19","pubTimestamp":1773191961,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical Inc. recently received FDA approval for a supplemental Biologics License Application expanding PALYNZIQ (pegvaliase-pqpz) use to pediatric phenylketonuria patients aged 12 and older, based on PEGASUS Phase 3 safety and efficacy data. \nThis approval broadens PALYNZIQ’s eligible patient population but comes with a REMS restriction due to immune-mediated risks including anaphylaxis, highlighting both opportunity and safety management demands for BioMarin. \nWe’ll now...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/palynziq-pediatric-label-expansion-under-rems-might-change-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/palynziq-pediatric-label-expansion-under-rems-might-change-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","IE00B7SZLL34.SGD","BK4139","IE00B19Z3581.USD","BMRN","IE00B19Z3B42.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617658696","title":"Absci names Ransi Somaratne chief medical officer as Andreas Busch set to retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658696","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658696?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:21","pubTimestamp":1772832073,"startTime":"0","endTime":"0","summary":"Absci Corporation appointed Ransi Somaratne, M.D., as Chief Medical Officer to lead clinical development for its AI-designed therapeutics pipeline. Somaratne previously served as Senior Vice President of Clinical Development at Vertex Pharmaceuticals and held leadership roles at BioMarin Pharmaceutical and Amgen. Chief Innovation Officer Andreas Busch will retire from his executive role on March 31, 2026. Busch will continue with the company as co-chair of Absci’s Scientific Advisory Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Absci Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL6SyRmp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU1430594728.SGD","IE00BZ9MQY76.HKD","AMGN","LU1057294990.SGD","IE0009355771.USD","LU0256863811.USD","LU2417539215.USD","LU0823416689.USD","LU0122379950.USD","LU0417517546.SGD","LU2236285917.USD","LU0868494617.USD","LU2324357040.USD","BK4581","LU1069344957.HKD","LU1674673428.USD","LU2362541513.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU1023059063.AUD","SGXZ57979304.SGD","BK4588","LU1983299246.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4121","ABSI","LU0058720904.USD","VRTX","LU0234570918.USD","IE00B894F039.SGD","SG9999001176.SGD","BMRN","BK4534","LU1061106388.HKD","BK4566","LU0061475181.USD","LU1035775433.USD","BK4599","IE00B19Z9P08.USD","LU0432979614.USD","BK4539","LU0109394709.USD","SG9999001440.SGD","IE00B19Z3581.USD","LU2468319806.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617576519","title":"Camp4 Therapeutics FY 2025 research and collaboration revenue rises 436.5% to USD 3.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576519","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576519?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:09","pubTimestamp":1772744997,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL7ZwvnJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE0002270589.USD","CAMP","BK4139","BMRN","BK4566","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616148559","title":"BioMarin Pharmaceutical Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2616148559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616148559?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:48","pubTimestamp":1772635680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMRN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2026 09:48 ET (14:48 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","BK4139","BK4566","BMRN","IE00B19Z3581.USD","IE0002270589.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616323533","title":"U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323533?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:14","pubTimestamp":1772615645,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan MaterialsMarch 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crowd","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nL4N3ZS0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITX","CRC","ORCL","MTH","ORCX","ORCU","CRWD","HON","MO","MARA","NCLH","NHI","OFRM","CAT","ACAD","CRWL","DUK","ADBE","NTLA","CMI","ANAB","BBY","TREE","FIGS","SWIM","ADBG","ITW","GTLB","KTB","MAAY","NCDL","BOX","CHYM","IMRA","ARCT","LTC","KBH","TGT","ORCS","LZ","BMRN","KBDC","MARO","FANG","GDRX","NVR","MRAL","LITE","AZO","DHI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616137292","title":"Amicus Therapeutics Inc. Held Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2616137292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616137292?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:55","pubTimestamp":1772574935,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics Inc. held a special meeting of stockholders on March 3, 2026. Stockholders approved the proposal to adopt the merger agreement for the pending acquisition by BioMarin Pharmaceutical Inc., and approved an advisory proposal related to merger-linked executive officer payments. The proposal to adjourn the meeting to solicit additional proxies, if needed, was not voted on.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amicus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLx9HC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0002270589.USD","IE00B19Z3B42.SGD","LU2065170008.USD","LU2065171311.SGD","IE00B7SZLL34.SGD","BK4139","FOLD","IE00B19Z3581.USD","LU2065171402.SGD","LU2065169927.USD","BMRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":167,"code":"91000000","status":"200"}]}}